Cryopyrin-Associated Periodic Syndromes Clinical Trials

11 clinical trials for Cryopyrin-Associated Periodic Syndromes across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load — RECRUITING · PHASE1
• Ilaris NIS in Korea — RECRUITING
• Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS) — RECRUITING · PHASE1
• Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase — COMPLETED · PHASE3
• Kineret CAPS Post Authorisation Study — COMPLETED
• A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) — OTHER · PHASE2
• Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease — COMPLETED · PHASE3
• Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease — COMPLETED · PHASE3
• HL2351 CAPS Phase II Study — TERMINATED · PHASE2
• Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease — COMPLETED · PHASE3
• Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients — COMPLETED

Refine this search